Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10965849 | Vaccine | 2013 | 8 Pages |
Abstract
A substantial number of patients with early-onset allergic symptoms met the most specific levels of the Brighton case definition but were not reported as anaphylaxis. Based on this specific case definition, the incidence of anaphylaxis after AS03-adjuvanted H1N1pdm09 vaccine substantially exceeded that reported with seasonal influenza vaccines, a signal that warrants better understanding.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Isabelle Rouleau, Gaston De Serres, Jean Philippe Drolet, Danuta M. Skowronski, Manale Ouakki, Eveline Toth, Monique Landry, Suzanne Ménard, Rémi Gagnon,